September 09, 2020

Chinese Biotech Sector is Blowing Hot as M&A and IPO Deals Surge Amid Covid-19 Pandemic

Toto Ku, Datasite Senior Sales Director, provides comments on the outlook for the Chinese biotech sector, including the surge in M&A and IPO deals amid the COVID-19 pandemic. The South Morning China Post article highlights findings from a recent webinar discussion on Deal Drivers in the Healthcare and Life Sciences: Mainland China.

  • Datasite for Healthcare

    Navigating the healthcare and life sciences industry has never been harder. Whether you’re looking at a licensing, listing or M&A, achieve your objective quickly and keep sensitive data secure with Datasite.

Contacts

Media Relations
Marta Carraro

Vice President, Communications

212.367.6162

[email protected]

Investor Relations
Jennifer Percy

651.632.4009

[email protected]

You may also like:

Good Value: Incorporating ESG Into M&A Due Diligence

Law.com has featured findings from the New State of M&A survey, as well as the recent Climate Change survey, in a story on incorporating ESG into M&A Due Diligence.

Law.com
Several Pandemic-Inspired Changes Here to Stay, Dealmakers Agree: Conference Insight

Comments from CMO and Head of Strategy Doug Cullen are featured in a Mergermarket article on how the pandemic has changed the way dealmaking gets done. The article highlights how Datasite has used remote and virtual tools to expand its talent pool.

Mergermarket An Acuris Company
Making Corporate Wellness Programs Work

CHRO Deb LaMere comments on how involving both employees and managers in the design and implementation of corporate wellness programs can yield benefits for both employer and employee. The article highlights how this strategy helped Datasite secure a +90% employee participation rate in one of its programs.